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Abstract
Viral diseases of the respiratory tract, which include influenza pandemic, children acute bronchiolitis, and viral pneumonia of
the elderly, represent major health problems. Plasmacytoid dendritic cells play an important role in anti-viral immunity, and
these cells were recently shown to express ChemR23, the receptor for the chemoattractant protein chemerin, which is
expressed by epithelial cells in the lung. Our aim was to determine the role played by the chemerin/ChemR23 system in the
physiopathology of viral pneumonia, using the pneumonia virus of mice (PVM) as a model. Wild-type and ChemR23 knock-
out mice were infected by PVM and followed for functional and inflammatory parameters. ChemR23
2/2 mice displayed
higher mortality/morbidity, alteration of lung function, delayed viral clearance and increased neutrophilic infiltration. We
demonstrated in these mice a lower recruitment of plasmacytoid dendritic cells and a reduction in type I interferon
production. The role of plasmacytoid dendritic cells was further addressed by performing depletion and adoptive transfer
experiments as well as by the generation of chimeric mice, demonstrating two opposite effects of the chemerin/ChemR23
system. First, the ChemR23-dependent recruitment of plasmacytoid dendritic cells contributes to adaptive immune
responses and viral clearance, but also enhances the inflammatory response. Second, increased morbidity/mortality in
ChemR23
2/2 mice is not due to defective plasmacytoid dendritic cells recruitment, but rather to the loss of an anti-
inflammatory pathway involving ChemR23 expressed by non-leukocytic cells. The chemerin/ChemR23 system plays
important roles in the physiopathology of viral pneumonia, and might therefore be considered as a therapeutic target for
anti-viral and anti-inflammatory therapies.
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Introduction
A number of single-stranded RNA viruses, including influenza
and respiratory syncytial virus (RSV) cause infections of the lower
respiratory tract and pneumonias, representing thereby a major
health problem worldwide. These viruses constitute a major cause
of hospitalization for acute bronchiolitis in infants and young
children (especially RSV), exacerbation of chronic obstructive
pulmonary disease (COPD), and viral pneumonia in the elderly
[1–4]. Animal models indicate that the severity of infections
caused by RSV or its mouse counterpart, the pneumonia virus of
mice (PVM), is due essentially to an excessive primary immune
response of the host, rather than the direct cytopathogenicity of
the viruses [5–8]. In line with these observations, administration of
anti-viral drugs was shown to have minimal impact on the clinical
outcome. Following an early and non-specific inflammatory
response characterized by the recruitment of neutrophils and
cytotoxic natural killer cells [9–10], a delayed adaptive immune
response leads, 7 to 10 days after infection, to an important influx
of CD8
+ cytotoxic T cells in the lung, and the production of RSV-
or PVM-specific antibodies by plasma cells [5,8,10]. Dendritic
cells (DCs) play a central role in the initiation of this adaptive
immune response. DCs capture viral antigens in the lung, undergo
a maturation process, and migrate to lymph nodes where they
activate naive CD4
+ and CD8
+ T cells [11–12]. In the lung, two
major subsets of dendritic cells have been described: CD11c
+
CD11b
+ MHC II
high F4-80
2 conventional, or myeloid, DCs (cDC
or mDC) and CD11c
low CD11b
2 Gr1
+ mPDCA-1
+ plasmacytoid
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DCs display a relatively weak antigen-presenting capability but
exert essential immuno-modulatory functions in asthma and viral
diseases[17].PDCsaremajorproducersoftypeIinterferons(IFNs),
including IFN-a and IFN-b, in response to the sensing of viral
components through Toll-like receptors (TLRs). Type I IFNs play a
crucial role ininnate anti-viral immunity, butalsoin the initiationof
adaptive immune responses [18]. Nevertheless, the role of pDCs in
the physiopathology of viral pneumonia is still unclear, as
discrepancies exist among published data. Indeed, some studies
performed with influenza virus or human RSV suggest a limited
role for pDCs [16,19,20] whereas depletion and adoptive transfer
experiments have demonstrated the ability of pDCs to inhibit viral
replication andenhanceviral clearanceinRSV-infected mice.They
also decrease airway hyperreactivity, lung inflammation and mucus
production, properties attributed to inherent anti-inflammatory
properties of pDCs [21,22]. Such anti-inflammatory activity of
pDCs is also described in asthma, in which pDCs mediate tolerance
through induction of regulatory T lymphocytes and suppression of
effector T cell generation [14,23–25].
ChemR23 is a G protein-coupled receptor, expressed by
immature DCs, macrophages and NK cells [26–28]. Its natural
ligand, chemerin, was purified from human inflammatory fluids
[29]. Chemerin, acting through ChemR23, has chemoattractant
properties at low and subnanomolar concentrations, particularly
for immature plasmacytoid DCs (pDCs) that express ChemR23 at
high levels [28,30,31]. Chemerin is synthesized as an inactive
precursor, prochemerin, which is present at high concentration in
plasma. Prochemerin can be rapidly converted into a full
ChemR23 agonist by neutrophil-derived serine proteases (elastase
and cathepsin G) and serine proteases of the coagulation and
fibrinolytic cascades, released as a result of tissue injury,
inflammation or infection [32,33].
Provided the expression of prochemerin in lung [28,29], its
processing by neutrophil proteases, the preferential expression of
ChemR23 by pDCs, and the role of pDCs and neutrophils in the
physiopathology of viral infections of the lung, we investigated the
potential involvement of the chemerin-ChemR23 system in pDC
recruitment and its functional consequences during viral pneu-
monia. We used wild-type (WT) and ChemR23 knock-out (KO)
mice in the PVM-induced acute pneumonia model and demon-
strated a crucial role of ChemR23 in the recruitment of pDCs to
the lung, the control of viral replication and clearance, as well as in
the dampening of excessive inflammatory responses. The en-
hanced inflammatory status and higher mortality rate of infected
ChemR23-deficient mice is however not due to the impairment of
pDC recruitment, but rather to the loss of an anti-inflammatory
role of chemerin through non-leukocytic cells.
Results
Enhanced mortality, morbidity, and respiratory
dysfunction in infected ChemR23
2/2 mice
After intranasal inoculation of PVM (1000 PFU) or control
medium (PBS), ChemR23
2/2 and wild-type C57BL/6 mice were
monitored daily for survival and weight loss. A significantly lower
survival rate was observed in ChemR23
2/2 mice as compared to
WT mice (21% vs 62% respectively; p,0.01) (Figure 1A).
ChemR23
2/2 mice began to lose weight one day ahead of WT
mice (i.e. at days 7 and 8 respectively, Figure 1A). Thereafter, the
weight curves were grossly parallel up to day 10, when WT mice
stabilized their weight before recovering, whereas ChemR23
2/2
mice continued to lose weight till day 12 included. Furthermore, at
days 8 and 9 post-infection, infected ChemR23
2/2 mice
presented a more severe pattern of illness signs, characterized by
motor slowing, hunching, fur ruffling, and crackles. It should also
be noted that the difference in weight loss remained significant at
late time points (days 12 to 16), when the more affected animals
had died, particularly in the infected ChemR23
2/2 group.
The differences in mortality rate and weight loss between
infected ChemR23
2/2 and WT mice correlated with the
pathological findings made on lungs collected at day 9 post-
infection (Figure 1B and 1C). Macroscopic examination of infected
lungs revealed numerous erythematous inflammatory foci, which
were larger and more numerous in Chem23
2/2 mice than in
controls (Figure 1B). As expected, such foci were never seen in
uninfected mice. At selected time points after infection, the lung
weight was recorded, as a reflect of inflammation and edema.
ChemR23
2/2 mice presented a higher lung weight increase (44%
over that of WT mice on average between day 6 and day 11)
(Figure 1B). Microscopic examination of the lungs clearly showed
stronger interstitial, peribronchiolar, and perivascular infiltrates
rich in neutrophils, lymphocytes and macrophages in infected
ChemR23
2/2 mice (Figure 1C).
Next, we investigated the respiratory function of the animals,
using a whole body double chamber plethysmograph (Figure S1).
No significant changes were observed up to day 6 post-infection.
At days 7 and 8 post-infection, while WT mice exhibited limited
changes of the various parameters, ChemR23
2/2 mice displayed
a severe restrictive syndrome likely resulting from the strong lung
edema and leukocyte infiltrate. This was characterized by a sharp
decrease (up to 50%) in tidal volume (p,0.01), a 2.3-fold increase
in end expiratory pause (p,0.05), a 3.4-fold increase in enhanced
pause (Penh) (p,0.001), and a 65% reduction in expiratory
balance (p,0.05) (Figure 1D and Figure S1). No difference in
airway resistance (sRaw) was observed between ChemR23
2/2 and
WT mice (Figure 1D). Plethysmographic analysis could not be
performed after day 8 post-infection, as a result of bioethical
limitations caused by the viral disease.
Chemerin increases in airways during viral infection
Chemerin, the agonist of ChemR23, was assayed by ELISA in
the broncho-alveolar lavage at several time points after infection.
Author Summary
Infections of the lower respiratory tract by single-stranded
RNA viruses represent a major health problem worldwide.
Animal models indicate that the severity of infections
caused by these viruses is due essentially to an excessive
primary immune response of the host, rather than the
direct cytopathogenicity of the viruses. Plasmacytoid
dendritic cells have been reported to play an important
role in anti-viral immunity, but the factors responsible for
the recruitment of these cells to the infected lung were
unknown. This study depicts the roles of the G protein-
coupled receptor ChemR23 in the recruitment of plasma-
cytoid dendritic cells and anti-viral immunity in a mouse
model of acute viral pneumonia. The data also highlight
the role of ChemR23 in dampening the lung inflammatory
response. This latter effect is independent of pDC
recruitment but involves non-leukocytic cells. This obser-
vation is of particular interest considering the established
role of airway endothelial and epithelial cells in the
immune responses following bacterial, viral and fungal
infections. Our results suggest therefore that the che-
merin/ChemR23 system might be considered as a target
for anti-viral and anti-inflammatory therapies.
Essential Role of ChemR23 in Viral Pneumonia
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both ChemR23
2/2 and WT mice (Figure 2A). However, they
were higher (4.5-fold on average) in ChemR23
2/2 mice at each
time point with the highest levels at day 10 (10.060.2 versus
2.160.4 ng/ml for WT, p,0.001). In order to investigate whether
elevated chemerin levels were the consequence of increased local
expression, chemerin transcripts were assessed by qRT-PCR
(Figure 2B). The data were normalized using two housekeeping
genes (YWHAZ and CANX) as references, and reported to the
chemerin transcript level in uninfected control mice. No significant
differences were observed according to infection status or
genotype. As the ELISA assays both active and inactive forms of
chemerin (including prochemerin), we tested chemerin bioactivity
in BAL fluids. Fractions resulting from a reverse phase HPLC
were tested in an aequorin-based intracellular Ca
2+ mobilization
assay. A biological activity was recorded for fractions obtained
from infected ChemR23
2/2 mice using CHO-K1 cells expressing
mouse ChemR23 (Figure 2C). Bioactivity was also retrieved from
infected WT mice, following sample concentration, while no
activity was observed in fractions from naive mice (data not
shown).
Increased viral load and delayed viral clearance in
ChemR23
2/2 mice
To assess the role of ChemR23 in viral replication and
clearance, immunofluorescence staining of lung sections with an
anti-PVM antibody was performed at days 6, 8, and 9 post-
infection. This allowed the observation of PVM-infected cells,
which include bronchiolar epithelial cells, type I and type II
pneumocytes, alveolar macrophages and eosinophils [34–36 and
unpublished observations] (Figure 3A). No noticeable difference
was observed at day 6 between WT and ChemR23
2/2 mice.
Thereafter, PVM staining remained stable in WT mice at day 8,
and decreased by day 9, whereas it increased in ChemR23
2/2
mice up to day 9. As a result, ChemR23
2/2 sections showed a
stronger and more diffuse staining than WT mice at day 8, and the
difference increased further by day 9. The enhanced viral
replication and reduced viral clearance in ChemR23
2/2 mice
were confirmed by the determination of the lung viral titers by
plaque assay (Figure 3B). The peak of viral titer was reached later
in ChemR23
2/2 than in WT mice (respectively at day 8 and
10 post-infection), and the titers were up to 100-fold higher
in ChemR23
2/2 than in WT mice (2.760.9610
6 versus 0.316
0.16610
6 PFU/lung at day 8, p,0.05; 5.264.5610
6 versus
9.162.9610
4 PFU/lung at day 9, p,0.01; 2.262.1610
4 versus
1706100 PFU/lung at day 10, p,0.05 respectively). As for
immunostaining, no difference in viral titers was apparent at day 6
(2.960.8610
4 for ChemR23
2/2 mice and 2.960.6610
4 PFU/
lung for WT mice, p.0.05). The delayed viral clearance in
ChemR23
2/2 mice was associated with a mild decrease in anti-
PVM antibodies in sera of ChemR23
2/2 mice at day 10 post-
infection, whereas this difference was abrogated at day 11
(Figure 3C).
Impaired type I IFN and IL-12p40 synthesis in infected
ChemR23
2/2 mice
We next investigated if the differences in clinical outcome and
viral clearance could be explained in part by differences in the
production of cytokines involved in anti-viral defenses. Various
cytokines were tested by qRT-PCR and/or ELISA in basal
conditions and at days 6, 8 and 10 post-infection. Most cytokines
peaked at day 8 post-infection and decreased by day 10 (Figure 4
and Figure S2). Type I interferons, including IFN-a and -b, are
known to play a central role in anti-viral immunity [18]. We first
assayed IFN-a and -b transcripts in lung by qRT-PCR (Figure 4A).
In contrast to WT mice, IFN-a and –b transcript levels increased
only slightly in ChemR23
2/2 mice and remained respectively 5-
fold and 4-fold lower than in WT mice at day 8 post-infection
(p,0.05). We confirmed by ELISA the lower levels of IFN-a in
ChemR23
2/2 compared to WT mice in lung homogenates
(49616 versus 158651 pg/ml respectively; p,0.05), and BAL
fluids (91626 versus 239646 pg/ml respectively; p,0.01) at day
8 post-infection. IFN-c production was also assessed by qRT-PCR
in lung, and using ELISA in lung, serum and BAL (Figure 4B and
Figure S2). The levels peaked at day 8 post-infection, with no
significant difference between ChemR23 KO and WT mice.
Interleukin (IL)-12 (or IL-12p70), another important cytokine
regulating the effector functions of lymphocytes, is composed of
two subunits, p40 and p35. The IL-12 p40 subunit was
investigated in lung, and significantly higher levels were found in
WT mice than in ChemR23
2/2 mice at days 8 and 10 post-
infection, both for the protein (2.5060.16 versus 1.4060.30 ng/
ml respectively at day 8, 1.3060.20 and 0.5060.03 ng/ml at day
10; p,0.05) (Figure 4B), and the transcript (,3-fold difference;
p,0.05) (Figure S2). As IL-12 p40 subunit is also shared by IL-23,
a heterodimeric cytokine promoting the synthesis of IL-17, IL-17
synthesis was assessed in lung homogenates by ELISA and qRT-
PCR, but no differences were observed between WT and
ChemR23
2/2 mice (Figure S2). IL-12 p70 was assayed by ELISA
and a cytometric bead array-based immunoassay, but remained
undetectable in BAL fluids and lung homogenates (data not
shown). ChemR23
2/2 mice displayed higher levels of IL-6 than
WT mice at day 8 and the difference became significant at day 9
(14476664 versus 288638 pg/ml respectively, p,0.01) and day
10 post-infection (13016328 versus 4546124 pg/ml respectively,
p,0.05). Although all these cytokines were increased during the
acute phase of the disease, no differences were observed between
KO and WT mice for lung TNF-a, IL-1b, IL-5, IL-10, IL-13, and
IL-17 (Figure 4B and Figure S2). Moreover, as neutrophils are
massively recruited during PVM infection, KC (CXCL1), a major
Figure 1. Higher mortality rate and more severe pathological features in ChemR23
2/2 mice infected by PVM. (A) Following intranasal
inoculation of PVM (1000 PFUs) or control medium, ChemR23
2/2 and wild-type (WT) C57BL/6 mice were monitored daily for survival (left panel) and
weight loss (right panel). Weight curves (mean 6 SEM) are relative to initial body weight. Differences were significant (p,0.05) between infected
wild-type (blue curve) and ChemR23
2/2 (red curve) mice from day 7 to day 16. The displayed data result from the pooling of four independent
experiments (n=40 for infected groups and n=10 for uninfected groups). (B) Macroscopic aspect of lungs collected from WT and ChemR23
2/2 (KO)
mice 9 days after PVM infection or PBS instillation. The weight of collected lungs was assessed at various time-points post-infection (right panel) and
expressed as percentage over lung weight of uninfected control mice. The data shown are the mean 6 SEM for groups of seven animals. (C)
Representative sections of lungs stained with hematoxylin and eosin. Scale bars: 500 mm for left panels, 50 mm for right panels. PVM-infected lungs
display perivascular (black arrows), peribronchiolar (white arrow), and alveolar inflammation (yellow arrows). (D) Respiratory dysfunction was
measured using a double chamber plethysmograph. Before and at selected time points after intranasal inoculation of PVM, tidal volume (TV) and
specific airway resistance (sRaw) were determined in wild-type and ChemR23
2/2 mice. The data shown are the mean 6 SEM for groups of four
animals. All displayed data are representative of at least three independent experiments. *, p,0.05; **, p,0.01.
doi:10.1371/journal.ppat.1002358.g001
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PLoS Pathogens | www.plospathogens.org 4 November 2011 | Volume 7 | Issue 11 | e1002358Figure 2. Increased chemerin levels in broncho-alveolar lavage fluid during PVM infection. (A) At selected time points after viral
inoculation, chemerin levels were determined by ELISA in BAL fluids of ChemR23
2/2 and wild-type C57BL/6 mice. (B) Chemerin transcript levels were
determined by quantitative RT-PCR. The data were normalized using two housekeeping genes (YWHAZ and CANX) as references, and reported to the
chemerin transcript level in uninfected control mice. The displayed data are the mean 6 SEM for groups of minimum seven animals. (C) The
biological activity of chemerin was measured in BAL fluids obtained at day 9 post-infection from wild-type (WT) and ChemR23
2/2 mice after a reverse
phase HPLC fractionation (C18 column) using an aequorin-based intracellular Ca
2+ mobilization assay. The data shown are the activity of fractions (25
to 50% acetonitrile) normalized to the response to ATP upon testing on CHO-K1 cells expressing mouse ChemR23 (CHO-ChemR23+) or not (CHO).
The functional response of mouse ChemR23-expressing CHO-K1 cells to recombinant mouse chemerin is shown as inset. Data are representative of
three independent experiments. *, p,0.05; **, p,0.01; ***, p,0.001.
doi:10.1371/journal.ppat.1002358.g002
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homogenates. KC levels increased to a peak value by day 8 post-
infection and remained significantly higher in ChemR23
2/2 mice
compared to WT mice at day 9 (86.4620.5 versus 28.362.2 pg/
ml respectively, p,0.01) and day 10 post-infection (50.365.4
versus 26.563.6 pg/ml respectively, p,0.01) (Figure 4B).
Figure 3. Increased viral load and delayed viral clearance in ChemR23
2/2 mice. (A) Immunofluorescent staining of viral antigens in lung
sections at 6, 8, and 9 days post-infection of wild-type (WT) and ChemR23
2/2 mice. Original magnification: 650. (B) Viral titers were determined in
lung homogenates for WT (open squares) and ChemR23
2/2 (filled triangles) mice at selected time points post-infection, and expressed in log10
plaque-forming units (PFU) per lung. (C) At days 9, 10, and 11 post-infection, the serum of infected mice was assessed for the presence of anti-PVM
antibodies by ELISA. The displayed data are the mean 6 SEM for groups of seven animals and are representative of at least two independent
experiments. *, p,0.05; **, p,0.01.
doi:10.1371/journal.ppat.1002358.g003
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plasmacytoid dendritic cells
To investigate the different leukocyte populations recruited
during the viral infection, cell suspensions were obtained from
digested lungs at different time points after PVM inoculation and
assessed by flow cytometry. As ChemR23 is highly expressed by
pDCs and is one of the few functional chemoattractant receptors
on these cells, the percentage and the absolute number of pDCs
were determined (Figure 5A). PDCs were identified as Gr-1
+
mPDCA
+ cells after a first gating on the CD11b
2 CD11c
+
population. The number of pDCs in uninfected ChemR23
2/2
mice did not differ from that in WT mice. A peak of pDCs was
reached at day 8 post-infection with, in WT mice, a 5.8-fold
increase from 11.760.8610
3 pDCs in basal conditions to
68.564.7610
3 pDCs per lung. In ChemR23
2/2 mice however,
the increase in pDCs was significantly lower than in WT mice
(Figure 5A). At day 8 post-infection, pDCs represented, respec-
tively in ChemR23
2/2 and WT mice, 0.3860.03% and
0.8560.06% of the total cell number (p,0.001). The correspond-
ing absolute numbers were respectively 42.064.4610
3 and
68.564.7610
3 pDCs per lung (p,0.01). Myeloid dendritic cells
(mDCs) were identified as CD11c
+ CD11b
+ cells after a first gating
on the MHC-II
high F4-80
2 population (Figure 5B). MDCs also
increased during viral challenge but, in contrast to pDCs, higher
values were found in ChemR23
2/2 than in WT mice. Indeed, at
day 8 post-infection, 14368610
3 mDCs were counted in
ChemR23
2/2 mice and 8867610
3 cells in WT mice (p,0.001).
This difference increased at day 10 with 175613610
3 mDCs in
ChemR23
2/2 and 9769610
3 mDCs in WT mice. Lung macro-
phages were defined as F4-80
+ CD11b
+ CD11c
2 cells and
neutrophils as Gr1
+ CD11b
+ CD11c
2 cells. The number of
macrophages and neutrophils increased from day 6 to day 10 post-
infection, reaching respectively 6.5- and 3.8-fold basal values
(Figure 5B). In ChemR23
2/2 mice, macrophages and neutrophils
were significantly higher than in WT mice at days 8 and 10 post-
infection. At day 10, macrophage counts were respectively
3.660.4610
6 and 2.460.1610
6 cells in ChemR23
2/2 and WT
mice (p,0.05), and neutrophil counts were respectively
2.560.3610
6 and 1.560.1610
6 cells (p,0.01). No differences
were observed between ChemR23
2/2 and WT mice for NK cells
(NK1-1
+ CD3
2), T cells (CD19
2 CD3
+) and B cells (CD19
+ CD3
2)
(Figure 5B). Flow cytometry analysis was also performed on BAL
fluids obtained at day 8 post-infection. Compared to uninfected
mice, a significant increase in pDCs was observed in the WT group
whereas this increase was not significant in ChemR23-deficient
mice. In ChemR23
2/2 mice, pDC counts reached only 50% of the
values observed in WT mice (5.660.7610
3 versus 11.462.2610
3,
p,0.05) (Figure 6A). As pDCs play an important role in anti-viral
immunity through their ability to synthesize type I IFN that
promote the cytotoxic response, the number of CD8
+ cytotoxic T
cells was determined in BAL fluids. Lower CD8
+ T cell counts were
found inChemR23KOmice(35.262.6610
3 versus 12.161.1610
3
for infected WT and KO mice respectively; p,0.001). No
difference was observed for CD4
+ T lymphocytes (7.760.8610
3
versus 7.561.1610
3 for WT and KO mice respectively; p.0.05)
(Figure 6A). Whereas neutrophil counts in BAL fluid did not differ
Figure 4. Reduced levels of type I IFNs and IL-12p40 in ChemR23
2/2 infected mice. At selected time points after infection, lungs and/or
broncho-alveolar lavage fluids obtained from wild-type (WT) (white bars) and ChemR23
2/2 mice (black bars) were assessed for cytokine transcripts or
proteins. (A) Lung IFN-a and IFN-b transcripts were assayed by qRT-PCR (upper panels). IFN-a levels were also determined by ELISA in lung
homogenates (lower left panel) and broncho-alveolar lavage fluids (lower right panel). (B) Chemokine (KC/CXCL1) and cytokines (IFN-c, TNF-a, IL-6, IL-
12p40 and IL-17) levels were determined by ELISA in lung homogenates. Data are the mean 6 SEM for groups of seven animals and are
representative of three independent experiments. *, p,0.05; **, p,0.01.
doi:10.1371/journal.ppat.1002358.g004
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difference was seen at day 10. Indeed, neutrophils represented the
main population in infected ChemR23
2/2 mice but not in WT
mice (respectively 53.567.6% and 6.561.1%; p,0.001). More-
over, the phenotype of BAL neutrophils in ChemR23 KO and WT
mice was evaluated at days 10 and 14 post-infection, using flow
cytometry.Nodifferencewas seen inthe neutrophil population (F4/
80
2, Ly-6G
+, CD11b
+), in terms of FAS and ICAM-1 expression,
which characterizethe antitumoral/pro-inflammatory‘‘N1’’ subset.
The phenotype of BAL macrophages (F4/80
+, Ly-6G
2, CD11b
+
cells) was also evaluated by flow cytometry at days 10 and 14 post-
infection and no difference between ChemR23 KO and WT mice
were seen for CD209a (DC-SIGN) expression as a marker of the
alternativelyactivatedand anti-inflammatory‘‘M2’’subset(datanot
shown). Altogether, these results do not support the recruitment of
different subsets of neutrophils or macrophages to the lungs of
infected ChemR23 KO and WT mice. The myeloperoxydase
activity was also higher in ChemR23
2/2 mice than in WT mice
(Figure S3). In contrast, lymphocytes were the main population in
WT mice at day 10 post-infection (38.066.1% versus 8.561.5% for
WT and ChemR23
2/2 respectively; p,0.01). No significant
differences were observed for cells categorized as macrophages on
the basis of their appearance on cytospin preparations (Figure 6B).
Increased immunopathology and mortality rate in
ChemR23
2/2 mice are not due to defective pDC
recruitment
Our data suggest the contribution of ChemR23 in pDC
recruitment, and impaired pDC recruitment in ChemR23
2/2
Figure 6. Decreased recruitment of pDCs and CD8
+ T lymphocytes and higher recruitment of neutrophils to the lung of infected
ChemR23-deficient mice. (A) Absolute numbers of pDCs, CD8
+ and CD4
+ T lymphocytes determined by flow cytometry in BAL fluids obtained
from wild-type (WT) (white bars) and ChemR23
2/2 mice (black bars), either non-infected or at day 8 post-infection. (B) Neutrophil counts were
determined in BAL fluids at different time points post-infection in WT and ChemR23
2/2 mice (left panel). Hematoxylin-eosin staining as well as the
relative cell counts performed on cytospin preparations (middle and right panels) from BAL fluids obtained from wild-type (white bars) and
ChemR23
2/2 mice (black bars) at day 10 post-infection are displayed. Data are the mean 6 SEM for groups of at least five animals. *, p,0.05; **,
p,0.01; ***, p,0.001.
doi:10.1371/journal.ppat.1002358.g006
Figure 5. Plasmacytoid dendritic cell recruitment to the lung is less efficient in ChemR23
2/2 mice during PVM infection. Inflammatory
cell subsets were assessed by flow cytometry in lung cell suspensions obtained from wild-type (WT) (white bars) and ChemR23
2/2 mice (black bars)
either naive or 6, 8, and 10 days after PVM inoculation. (A) Plasmacytoid dendritic cells (pDC) were determined as the Gr-1
+ mPDCA
+ population after
gating on CD11b
2 CD11c
+ cells (upper panels). The lower panels display respectively the percentage and absolute numbers of pDCs. (B) Absolute
numbers of myeloid dendritic cells (mDC, CD11c
+ CD11b
+ MHC II
high F4-80
2 cells), lung macrophages (F4-80
+ MHC II
low CD11b
+), neutrophils (Gr1
+
CD11b
+ CD11c
2), NK cells (NK1-1
+ CD3
2), T (CD19
2 CD3
+) and B (CD19
+ CD3
2) lymphocytes at selected time points after infection. Data are the
mean 6 SEM for groups of at least five animals and are representative of at least three independent experiments. *, p,0.05; **, p,0.01; ***, p,0.001.
doi:10.1371/journal.ppat.1002358.g005
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delayed viral clearance. In order to test the potential link between
this cascade of events and the increased morbidity/mortality
observed in KO mice, we performed pDC depletion and adoptive
transfer experiments. Depletion of pDCs was achieved by
intraperitoneal injections of the 120G8 monoclonal antibody,
starting before PVM inoculation. Staining of spleen cells obtained
at day 9 post-infection confirmed the efficacy of the protocol. With
the exception of B cells, which were slightly but significantly
(p,0.05) decreased in the depleted WT group, no effect of the
depleting antibody was observed on other subsets of inflammatory
cells, including mDCs, macrophages and T cells (Figure 7A and
Figure S4). Following PVM infection, a higher mortality rate
(55%) was observed for ChemR23
2/2 mice (Figure 7A), in line
with our previous experiments. However, pDC depletion in WT
mice did not increase their mortality rate, compared to WT mice
treated with a control IgG. Furthermore, pDC depletion did not
reduce the difference in mortality rate between WT and
ChemR23
2/2 mice.
Adoptive transfer of pDCs was also performed. PDCs were
purified from the spleen of WT and ChemR23
2/2 mice
overexpressing Flt3 ligand. The generated pDCs were tested for
their phenotype and functionality, and no difference in their ability
to synthesize cytokines (IFN-a and IL12p40) in response to CpG
stimulation was detected in vitro (Figure S5). Moreover, pDCs from
WT mice were able to migrate in response to chemerin with a
typical bell-shaped curve culminating for concentrations around
1 nM, whereas pDCs from KO mice failed to migrate in response
to chemerin (Figure S6). If defective pDC recruitment was causal
in the differences observed between WT and ChemR23
2/2 mice,
we expected that adoptive transfer of ChemR23-expressing pDCs
to knock-out mice would reduce the mortality and weight loss in
this group, as compared to knock-out mice receiving either pDCs
from KO mice or a saline solution. Interestingly, these experi-
ments showed the opposite effect (Figure 7B). ChemR23
2/2 mice
receiving a saline solution or pDCs from knock-out mice presented
similar weight and survival curves, whereas ChemR23
2/2 mice
receiving pDCs from WT mice displayed higher weight loss and
mortality rate. We also observed more severe clinical signs in these
animals, particularly reduced locomotor activity and increased
crackles. These observations were complemented by the analysis
of cells in BAL fluids, using flow cytometry. We showed that
ChemR23
2/2 mice receiving pDCs from WT mice displayed
an increase in the number of cells in BAL, as compared to
ChemR23
2/2 mice receiving pDCs from KO mice, 14 days after
infection/adoptive transfer of pDCs. The cells were mainly
CD3
+CD4
+ and CD3
+CD8
+ T lymphocytes, while neutrophils
were low at that time (Figure 7C). In these settings, pDCs, NK
cells and macrophages were low (data not shown). Analysis of the
cytokine levels in BAL fluid showed a sustained production of IL-6
compared to WT mice and higher levels of IFN-c compared to
WT and KO mice (Figure S7), while levels of KC were unchanged
and no IL-10 was detected at this time-point (data not shown).
Finally, the restoration of the IFN-a production was detected using
ELISA in the BAL fluid of ChemR23
2/2 mice receiving pDCs
from WT mice, as compared with levels in the BAL fluid of WT
mice (Figure 7D).
The inflammatory phenotype of KO mice is not due to
the lack of ChemR23 expression by leukocytes
As lower pDC recruitment does not explain the higher
immunopathology observed in ChemR23 KO mice, we further
characterized the role of ChemR23 expression by leukocytes
versus non leukocytic cells in PVM infection pathogenesis. To
address this question, irradiated WT and KO mice were
reconstituted with bone marrow (BM) cells harvested from KO
and WT mice respectively, in order to generate WT mice having
ChemR23-deficient leukocytes and conversely. Chimerism was
assessed by flow cytometry 6 weeks post-irradiation and we
observed that more than 90 percent of CD45
+ spleen cells resulted
from the graft (GFP-positive cells; 94.061.5%; mean 6 SEM for
n=6 independent experiments). Irradiated and reconstituted mice
presented a lower susceptibility to PVM infection than sex- and
age-matched non-irradiated mice (data not shown). This observa-
tion is in line with previously published data showing lower
asbestos-induced lung inflammation after myelo-ablative irradia-
tion and BM transplantation [37]. As a result, all mice survived the
PVM challenge and a relatively mild weight loss was observed. As
shown in Figure 8, KO mice reconstituted with WT leukocytes
presented higher weight loss and displayed more severe illness
signs than WT mice reconstituted with KO leukocytes. At the end
of the observation period, mice were sacrificed and higher
numbers of neutrophils, macrophages, CD8
+ and CD4
+ T cells
were recovered in BAL fluids of KO mice reconstituted with WT
leukocytes (Figure 8A). These observations were confirmed in
other experiments in which BAL fluids were harvested earlier (day
14 post-infection), and including additional groups of WT and KO
mice reconstituted respectively with WT and KO mice (Figure 8B).
Higher numbers of inflammatory leukocytes were found in BAL
fluids of KO mice grafted with BM from KO mice, than in the two
WT groups. However, as in the first experiment, KO mice
reconstituted with WT leukocytes presented much higher BAL cell
counts, as well as IL-6 and IFN-c levels.
Discussion
In this study, we investigated the role of the chemerin-
ChemR23 system in a mouse model of viral pneumonia. Wild-
type and ChemR23 knock-out mice were infected by PVM, the
mouse counterpart of human RSV. The two viruses are closely
related and evoke similar immune responses. The use of the
natural mouse pathogen PVM was however preferred, because it
replicates efficiently following a minimal virus inoculum, and
recapitulates many of the clinical and pathologic features of the
most severe forms of RSV infection in human infants. By contrast,
mice are relatively resistant to infection by human RSV [10].
We demonstrated that ChemR23
2/2 mice develop a more
severe inflammatory status than wild-type mice, resulting in a
significant increase in morbidity and mortality rate. ChemR23
2/2
mice presented a higher recruitment of neutrophils and macro-
phages, higher myeloperoxydase activity, extended macroscopic
and microscopic lesions, increased synthesis of pro-inflammatory
cytokines (e.g. IL-6) and chemokines (e.g. CXCL-1/KC) and higher
levels of bioactive chemerin in the lung. As a direct consequence,
ChemR23-invalidated mice showed a more severe respiratory
dysfunction (restrictive syndrome), evaluated by double chamber
whole body plethysmography. We demonstrated a lower recruit-
ment of pDCs to the lung of ChemR23
2/2 mice, despite a 100-
fold higher viral load. In line with the high expression of
ChemR23 on immature plasmacytoid dendritic cells and the
chemoattractant activity of chemerin on pDCs in vitro, our data
strongly suggest a major role of the chemerin/ChemR23 system in
the recruitment of pDCs in vivo. This observation correlates with
other studies reporting a link between chemerin expression and
the recruitment of pDCs and NK cells in human inflammatory
diseases of the skin [27,31,38,39]. The recruitment to lung of other
ChemR23-bearing cells, including macrophages, myeloid dendrit-
ic cells and NK cells was apparently not affected in ChemR23
2/2
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ChemR23 on these cells and the redundancy with other
chemoattractant molecules able to recruit these cell populations
[31,40,41]. In this context, the higher number of mDCs and
macrophages observed in lungs of infected ChemR23
2/2 mice
might be explained by the higher inflammatory state and the
higher production of chemokines acting independently of the
chemerin/ChemR23 system. Chemerin levels were found to be
increased in lung and airways during viral infection, reaching
higher values in ChemR23
2/2 mice than in controls. As
prochemerin transcript levels did not change during the course
of the disease, the strong upregulation of chemerin in lung likely
results from exudation of circulating prochemerin. The observa-
tion of bioactivity on ChemR23-expressing cells demonstrates that
prochemerin was also processed to its active forms, presumably in
part by neutrophil proteases. Chemerin and neutrophil recruit-
ment increase indeed in parallel during the course of infection.
The higher levels of chemerin immunoreactivity and bioactivity in
ChemR23
2/2 mice may be explained in part by the stronger
inflammatory response, resulting in more exudation and more
efficient activation of prochemerin by proteases released by the
higher number of neutrophils. However, basal immunoreactive
chemerin levels are also increased in uninfected animals. Increased
(pro)chemerin levels may therefore also result from defective
removal of the protein from extracellular fluids, resulting from the
lack of receptors (ChemR23) able to bind and internalize
chemerin. This hypothesis of chemerin scavenging by
ChemR23-positive cells is supported by similar observations made
Figure 8. Transfer of bone marrow from wild-type mice does not protect ChemR23-deficient mice from PVM infection. (A) Irradiated
(*) wild-type mice reconstituted with ChemR23
2/2 bone marrow (WT*+KO), as well as irradiated KO mice reconstituted with bone marrow from WT
mice (KO*+WT), were infected by PVM (1000 PFUs) and monitored for weight loss (left panel). 23 days post-infection, mice were sacrificed and
inflammatory cells were counted in BAL fluids (right panel). (B) BAL fluids were also harvested at day 14 post-infection in a similar experiment
including two additional groups, namely WT and KO mice reconstituted respectively with WT and KO bone marrow (WT*+WT, KO*+KO, respectively).
Total cell numbers (left panel) as well as cytokine levels (IL-6 and IFN-c, middle and right panels) were determined in these samples. Data are the
mean 6 SEM for groups of at least five animals. *, p,0.05; **, p,0.01.
doi:10.1371/journal.ppat.1002358.g008
Figure 7. Increased pathogenicity of PVM in ChemR23
2/2 mice is not due to the defective pDC recruitment. (A) Depletion of pDCs was
achieved by using the 120G8 monoclonal antibody in wild-type (WT) and ChemR23
2/2 (KO) mice infected by PVM. Depletion efficacy was assessed
by flow cytometry analysis of pDCs (CD11b
2 CD11c
+ B220
+ mPDCA
+) among spleen cells collected at day 8 post-infection (left panel). Survival was
recorded for infected WT and ChemR23
2/2 mice, depleted or not in pDCs (n=7 per group) (right panel). (B)1 0
6 pDCs from WT or ChemR23
2/2 mice
were transferred intravenously into knock-out mice at the time of infection with PVM. Knock-out mice receiving a saline solution were used as
controls. Survival (left panel) and body weight (right panel) were monitored (n=6 per group). (C)1 0
6 pDCs from WT or ChemR23
2/2 mice were
transferred intravenously into ChemR23
2/2 mice at the time of infection (n=7 per group). Infected wild-type and knock-out mice receiving a saline
solution were used as controls (n=5 per group). Mice were sacrificed 14 days after infection and the cell populations were analyzed in BAL fluids
using flow cytometry. Histograms show the mean 6 SEM for total cell numbers and absolute numbers of neutrophils, CD3
+CD4
+ and CD3
+CD8
+ T
lymphocytes. (D)1 0
6 pDCs from WT mice were transferred intravenously into ChemR23
2/2 mice at the time of infection. Infected wild-type and
knock-out mice were used as controls. IFN-a levels were detected 9 days after infection in BAL fluids using ELISA (n=5 per group). *, p,0.05; **,
p,0.01, ***, p,0.001.
doi:10.1371/journal.ppat.1002358.g007
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circulating levels of the corresponding chemokine ligands were
found to be elevated, as described for the CCL2/CCR2 axis [42].
PDCs play an important role in anti-viral immunity by their
capacity to secrete large amounts of type I IFNs (including IFN-a
and -b) and induce effector CD8
+ T-cell response upon viral
infection [13]. Type I IFNs have pleiotropic anti-viral functions:
they increase the resistance of non-infected cells to viral infection,
inhibit viral gene transcription, induce apoptosis of infected cells,
induce B cell differentiation into antibody-secreting plasma cells,
promote the cytotoxic activity of NK and CD8
+ T cells, promote
survival and proliferation of CD8
+ T cells, as well as differentiation
and maturation of DCs [18,43–46]. As a result, type I IFNs
promote an efficient acquired immune response and facilitate viral
clearance in PVM-induced mouse pneumonia models [7]. In
PVM-infected ChemR23
2/2 mice, it is therefore tempting to link
the defective pDC recruitment to the lower synthesis of type I
IFNs, lower acquired immune response (low CD8
+ T cell counts
and IL-12p40 production), and delayed viral clearance. In this
context, parameters unaffected (IFN-c production) or displaying
mild differences (anti-PVM antibodies production) must be
interpreted taking into account a 100-fold higher viral load in
ChemR23 KO mice. In our study, no difference in viral loads
were observed before day 8 post-infection, suggesting that intrinsic
viral replication of PVM was not affected by ChemR23 deficiency.
Moreover, replication of PVM was reported in type I and II
pneumocytes, alveolar macrophages, eosinophils, and bronchiolar
epithelial cells, which are not described to express ChemR23 [34–
36,47 and unpublished observations].
Therefore, to investigate whether lower recruitment of pDCs in
PVM-infected ChemR23
2/2 mice might explain the excessive
morbidity, pDC depletion and adoptive transfer experiments were
performed. In depletion experiments, mortality rates were
essentially unchanged both in WT and ChemR23
2/2 mice,
suggesting that pDCs do not play a major role in the poor clinical
outcome of PVM-infected ChemR23
2/2 mice. Moreover,
adoptive transfer of ChemR23-expressing pDCs to KO mice
enhanced clinical symptoms and decreased survival. Interestingly,
previous studies have shown that C57BL/6 mice lacking type I
IFN receptor (IFN-abR
2/2) or functional TCR exhibit defective
acquired response and higher PVM titers, but milder histological
lesions, decreased PMN recruitment and lower mortality rate
[7,8]. Taken together, these observations strongly suggest that the
extent of lung tissue damage is not directly related to the viral load,
but rather to the efficiency of the anti-PVM immune response,
including the acquired Th1 component. In this context, improving
the immune response by transferring ChemR23-expressing pDCs
may indeed lead to a more severe lung disease. In other models
however, pDC depletion resulted in an enhancement of the
inflammatory state. In pDC-depleted BALB/c mice infected by
human RSV, a higher Th2 response was observed, which was
found to be IFN-independent [21]. PDC depletion in BALB/c
mice also resulted in enhanced airway inflammation and
eosinophilia in asthma models, whereas adoptive transfer of pDCs
suppressed inflammation and the Th2 response [25]. This
immunomodulatory role of pDCs on Th2 responses is type I
IFN-independent and mediated by their ability to induce
regulatory T lymphocytes and/or to suppress effector T cell
generation [14,23–25]. The influence of pDCs may therefore
affect the inflammatory state positively or negatively, according to
the specific model considered and the main immune responses
triggered in this model.
As defective pDC recruitment did not appear to underlie the
more severe clinical outcome observed in ChemR23 KO mice, we
hypothesized that these mice might have lost a direct anti-
inflammatory pathway involving ChemR23. This hypothesis is
indeed supported by previous results from our group, showing a
ChemR23-dependent anti-inflammatory role of chemerin in a
LPS-induced acute lung inflammation model [28]. To assess
whether this anti-inflammatory effect is mediated by ChemR23-
expressing leukocytes or other cell populations, chimeric mice
were generated following lethal irradiation and BM adoptive
transfer. These experiments showed that mice lacking ChemR23
only in BM-derived cells behaved essentially as wild-type animals,
while restoring ChemR23-expression in leukocyte populations did
not protect KO mice from excessive inflammatory response to
PVM infection. It appears therefore that the chemerin/ChemR23
system has anti-inflammatory properties on a non-leukocytic cell
population, which is presently not identified. Lung endothelial cells
might constitute a candidate cell population, since ChemR23
expression was recently described in human endothelial cells
[48,49]. Chemerin might therefore regulate trafficking of inflam-
matory cells such as PMNs, by modulating the release of
chemokines by endothelial cells, or their interactions with
leukocytes. Finally, our chimera experiments showed that mice
expressing ChemR23 exclusively in leukocytes displayed the most
severe inflammatory phenotype, with the highest levels of IFN-c
and CD8 T cells in BAL fluids. Similar results were obtained
following adoptive transfer of ChemR23-expressing pDCs in KO
mice. These observations suggest that ChemR23-expressing
leukocytes, among which pDCs, contribute significantly to the
innate and acquired cytotoxic responses and the resulting
inflammatory insult to lung parenchyma.
In conclusion, ChemR23-deficient mice are more susceptible to
PVM infection. The recruitment of pDCs is impaired in these
mice, resulting in a reduction of type I IFN synthesis and delayed
viral clearance. However, the stronger inflammatory status and the
resulting higher morbidity and mortality, are not the consequence
of impaired pDC recruitment. Chemerin appears therefore to
have anti-inflammatory properties, by acting on ChemR23
expressed by non-leukocytic cells, thereby dampening the
inflammatory response promoted by the viral infection. Further
analyses are needed to determine the precise underlying
mechanisms and cell types involved in these processes.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
national, european (EU Directives 86/609/EEC) and internation-
al guidelines in use at the Universite ´ Libre de Bruxelles. All
procedures were reviewed and approved by the ethical committee
(Commission d’Ethique du Bien-Etre Animal, CEBEA) of the
Universite ´ Libre de Bruxelles (Permit Number: 222N and 341N).
All efforts were made to minimize suffering.
Mice
Eight to twelve weeks-old C57BL/6 mice (Harlan Netherlands)
were used throughout these studies. ChemR23-deficient mice
(KO) were obtained from Deltagen (CA, USA) through Euro-
screen S.A. (Brussels, Belgium). They were backcrossed for 12
generations into the C57BL/6 background in a specific pathogen
free environment. Wild-type littermates from F1 matings were
used as controls.
PVM-induced viral pneumonia model
The J3666 strain of PVM (initially provided by A.J. Easton) was
passed in BALB/c mice and grown once onto BSC-1 cells to
Essential Role of ChemR23 in Viral Pneumonia
PLoS Pathogens | www.plospathogens.org 13 November 2011 | Volume 7 | Issue 11 | e1002358produce the viral stock. Randomly selected aliquots of the stock
yielded highly reproducible titers on BSC-1 cells, amounting to
1610
6 PFU/ml. Mice were inoculated under brief anaesthesia
(ketamine, Pfizer, 50 mg/kg, and xylazine, Bayer, 10 mg/kg, i.p.)
by intranasal instillation of 50 ml of a viral suspension containing
1000 PFU and 1% BSA in PBS. Control mice were inoculated
with PBS containing 1% BSA. At selected time intervals (6, 8 and
10 days post-infection), groups of minimum 6 mice were sacrificed
with sodium thiopental (5 mg/animal, i.p.). In some experiments,
broncho-alveolar lavage fluids were obtained by flushing the lungs
with sterile 0.9% NaCl, and differential cell counts were
performed on cytospin preparations after Diff-Quick staining
(Dade Behring).
Whole body plethysmography
Lung function was assessed in groups of five mice using a whole
body double chamber plethysmograph (Buxco) and IOX software
(EMKA Technologies) as described previously [50]. Briefly, at
selected time points (before inoculation and 1, 3, 5, 6, 7 and 8 days
post-inoculation), awake mice were placed between two compart-
ments (nasal and thoraco-abdominal), in which flow variations
were recorded during 5 minutes and used to determine the
following parameters: tidal volume (TV); expiratory balance; RT/
Te, in which RT is the relaxation time determined as the time
needed to expire 64% of the inspired volume and Te the
expiratory time; end expiratory pause (EEP), Te – RT; enhanced
pause (Penh); specific airway resistance (sRaw).
Lung histological analysis and anti-PVM immunostaining
At day 9 post-infection, left lungs were insufflated with 500 mlo f
4% paraformaldehyde, and embedded in paraffin. Sections (5 mm)
were stained with haematoxylin and eosin and assessed by light
microscopy. Paraffin embedded lung sections (5 mM) were also
used for PVM antigen immunofluorescence staining using an anti-
PVM antiserum (dilution 1/100, rabbit) and an Alexa Fluor 488-
conjugated anti-rabbit IgG antibody (dilution 1/1000, Invitrogen).
Images were captured with an Axioplan 2 imaging fluorescence
microscope, equipped with a Diagnostic Spot digital camera and
analyzed by the Spot Advanced Soft Imaging System and Adobe
Photoshop 7.0. The lenses used were 206/0.5, ‘/0.17; 406/0.75,
‘/0.17 and 1006/1.30, ‘/0.17.
Viral titration
At selected time points, viral titers were determined by standard
plaque assay as previously described [34]. Briefly, the right lung
was homogenized in PBS containing 1% BSA and successive 10-
fold dilutions of the supernatant were used to infect BSC-1 cell
cultures. The viral suspensions were left to adsorb for 3 h at 31uC,
after which the cell monolayers were covered with 1 ml of 0.6%
agarose in MEM containing 2% FBS. After incubation at 31uC for
12 days, the agar overlay was removed, the remaining cells were
stained with crystal violet, and titers were determined by counting
the number of plaque forming units (PFUs).
Detection of PVM antibodies in serum
The serum was evaluated for anti-PVM antibodies on days 9,
10, and 11 post-inoculation and compared to serum obtained from
control mice using the SMART-M12 kit (Biotech Trading
Partners).
Quantitative RT-PCR
Lung total RNA was extracted and purified using the RNeasy
Mini Kit (Qiagen). After DNase I treatment (Ambion), samples
were reverse transcribed into cDNA using random hexamers
(Roche) as primers and the Superscript II polymerase (Invitrogen).
RT-PCR products were analyzed by quantitative real-time RT-
PCR. The sequence of primer pairs used for mouse chemerin,
IFN-a, IFN-b, CANX, and YWHAZ is provided in Table S1.
Raw data were normalized for each sample using YWHAZ and
CANX gene expression as references.
Cytokine assays
At selected time points, right lungs were homogenized in PBS
and supernatants were assayed for TNF-a, IL-6, IFN-c and KC/
CXCL1 using cytometric bead array-based immunoassays (CBA
Flex set, BD Biosciences), a dual-laser flow cytometer (FACSCa-
libur, BD Biosciences) and the FCAP Array software (BD
Biosciences) for analysis, following the manufacturer’s instructions.
IL-12p40, IL-17, chemerin, and IFN-a were determined by
ELISA in lung homogenates (R&D Systems, Abingdon, UK).
Chemerin, as well as IL-6, TNF-a, IL-10, IFN-c (BD Biosciences),
IFN-a and KC (R&D Systems) were also measured in BAL fluids
using ELISA according to the manufacturer’s instructions.
Biological activity of BAL chemerin
BAL fluids from two infected WT and ChemR23
2/2 mice were
pooled, filtered and loaded onto a C18 reverse phase column
(2.16250 mm; Vydac). Fractions from a 25–50% acetonitrile
(CH3CN) gradient (0.5%/min) in 0.1% TFA were collected. The
biological activity was next measured by a calcium-mobilizing
assay based on the bioluminescence of aequorin, using CHO-K1
cells co-expressing mouse ChemR23, apoaequorin and Ga16 [30].
CHO-K1 cells co-expressing only apoaequorin and Ga16 were
used as control. Fractions from infected WT mice were also
concentrated and depleted of acetonitrile using a vacuum
SpeedVac concentrator and then tested undiluted in the same
assay. Results (expressed as luminescence units) were normalized
to the response to 20 mM ATP. A dose-response curve for
chemerin on ChemR23-positive CHO-K1 cells was also generated
using 0.01 to 100 nM recombinant mouse chemerin (R&D
Systems).
Flow cytometry
Lungs were perfused with 10 ml PBS through the right
ventricle, dissected, minced, and incubated with 2 mg/ml
collagenase D and 0.02 mg/ml DNAse I (Roche) for 1 hour at
37uC. In some experiments, cell suspensions were obtained from
BAL fluids as previously described. After lysis of red blood cells
and blockade of non-specific binding to FcR with anti-CD16/
CD32 monoclonal antibodies (mAbs), viable cells were counted by
trypan blue exclusion. Cells were stained with mAbs directed
against F4/80 (FITC or APC), CD11b (FITC or PerCp-Cy5.5),
CD4 (FITC or Horizon V450), CD11c (PE or APC), I-A/I-E (PE),
CD19 (PE), NK1-1 (PE), Gr-1 (PerCp-Cy5.5), Ly6-G (Alexa 700),
CD8 (PerCp or Horizon V500), ICAM-1 (PE), CD95 (PE-Cy7),
CD209a (biotinylated), Streptavidin-FITC, CD3 (APC), mPDCA
(APC), and isotype controls (all from BD Biosciences except F4/
80-FITC from AbD Serotec). All samples were analyzed using a
dual-laser flow cytometer (FACSCalibur) using the CellQuest
software (BD Biosciences) or a four-laser flow cytometer (FACS
LSRFortessa) using FACS Diva software (BD Biosciences).
Depletion of pDCs
Depletion of pDCs was performed in WT and ChemR23
2/2
mice using a monoclonal antibody against pDCs (120G8,
Dendritics). Mice received four i.p. injections of 125 mg 120G8,
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efficacy and specificity was assessed by assaying cell populations in
spleen. After mechanical disruption, isolated spleen cells were
stained for pDCs, mDCs, macrophages, T and B cells using the
following set of antibodies: B220 (FITC), CD11c (PE), CD11b
(PerCp-Cy5.5), mPDCA (APC); or F4-80 (FITC), CD19 (PE),
CD11b (PerCp-Cy5.5) and CD3 (APC).
Adoptive transfer of pDCs
The generation, purification and transfer of isolated pDCs were
performed as previously described [25]. Briefly, wild type and
ChemR23
2/2 mice were injected subcutaneously with 5610
6
melanoma B16 cells (syngeneic to C57BL/6 mice) expressing the
dendritic cell growth factor FMS-like tyrosine kinase 3 ligand
(Flt3-ligand) (kindly provided by M. Moser, ULB, Gosselies).
Three weeks later, mice were sacrificed and their spleen
mechanically disrupted. Released cells were then passed through
a7 0mM cell strainer (BD Biosciences). Untouched pDCs from
single-cell suspensions were then isolated by negative selection
(Plasmacytoid Dendritic Cell Isolation Kit II, Miltenyi Biotec).
Briefly, non-pDC cells were labelled with a cocktail of biotin-
conjugated monoclonal antibodies and depleted by retention on a
MACS column. The viability and purity of the pDC preparations
were respectively over 95% and 90%, as assessed by flow
cytometry following staining using respectively propidium iodide
(PI) and mAbs against B220 (FITC), CD11c (PE), CD11b (PerCp-
Cy5.5) and mPDCA (APC) (all from BD Biosciences). Thereafter,
10
6 pDCs from WT mice in 0.9% NaCl were injected in the tail
vein of ChemR23
2/2 mice infected the same day by PVM.
Weight loss and mortality rate were compared between this group
(KO+pDC WT), infected ChemR23
2/2 mice receiving the saline
carrier (KO+0.9% NaCl), and infected ChemR23
2/2 mice
receiving 10
6 pDCs purified from ChemR23
2/2 mice (KO+pDC
KO).
Bone marrow transplantation and generation of chimeric
mice
Chimeric mice were generated to discriminate between the roles
of ChemR23 expressed by leukocytes or other cell types. For this
purpose, 8 week old WT and ChemR23 KO mice received a
lethal irradiation dose of 800 Rad TBI delivered by a
137Cesium
irradiator. Twenty four hours later, irradiated mice were
reconstituted by i.v. injection with 20610
6 syngeneic BM cells
isolated from 6 to 8 week old WT or KO mice. BM cells were
obtained by flushing BM from femurs and tibiae of donor mice.
After 4 weeks, mice were infected and chimerism was assessed on
spleen cells purified from mice reconstituted with BM cells from
age-matched WT C57BL/6 mice expressing green fluorescent
protein (GFP) (% GFP
+ cells among CD45
+ spleen cells).
Statistical analysis
Significance was determined using Student’s t test or one-way
analysis of variance, using the Prism4 software (GraphPad). The
Student-Newman-Keuls test was used for pairwise comparisons.
Kaplan-Meier survival curves were compared using the logrank
test. For all tests, p,0.05 was considered as significant.
Accession numbers
(Source: http://www.ncbi.nlm.nih.gov) [Mus musculus]
Chemerin: 71660/NP082128; ChemR23/cmklr1: 14747/
P97468; TNF-a: 21926/CAA68530; IL-10: 16153/NP034678;
TGF-b1:21803/AAH13738; KC/CXCL-1: 14825/P12850; IL-6:
16193/P08505; IFN-a: 15962/P01572; IFN-b: 15977/P01575;
IFN-c: 15978/P01580; IL-5: 16191/P04401; IL-13: 16163/
P20109; IL-17: 16171/Q62386; IL-12p40: 16160/P43432; IL-
1b: 16176; CANX: 12330; YWHAZ: 22631.
Supporting Information
Figure S1 Assessment of respiratory functional param-
eters in PVM-infected wild-type and ChemR23
2/2 mice
using a whole-body double chamber plethysmograph.
Lung function was assessed using a double chamber plethysmo-
graph. (A) Awake mice were placed between the two compart-
ments (nasal and thoraco-abdominal) of the instrument, flow
variations were recorded and the following functional parameters
were determined: inspiratory time (Ti); expiratory time (Te); peak
inspiratory flow (PIF); peak expiratory flow (PEF); tidal volume
(TV); expiratory balance (RT/Te), in which RT is the relaxation
time determined as the time needed to expire 64% of the inspired
volume; end expiratory pause (EEP), Te - RT; and enhanced
pause (Penh), ((TE/RT)-1)x(PEF/PIF) (E4). (B) Before and at
selected time points post-infection, ChemR23
2/2 (closed circles)
and wild-type (WT) (open circles) mice were assessed for
respiratory function. Whereas no significant changes were
observed in WT mice, ChemR23
2/2 mice displayed severe
changes at days 7 and 8 post-infection, consistent with marked
respiratory dysfunction and more specifically a restrictive syn-
drome. Along with a reduction in tidal volume, ChemR23
2/2
mice displayed a 2.3-fold increase in end expiratory pause
(p,0.05), a 3.4-fold increase in enhanced pause (Penh)
(p,0.001), and a 65% reduction in expiratory balance (p,0.05).
The displayed data are the mean 6 SEM for groups of at least
four animals, and are representative of two independent
experiments. *, p,0.05; ***, p,0.001.
(TIF)
Figure S2 Cytokinic profile in lung determined by
ELISA and quantitative RT-PCR. (A) Lung total RNA was
extracted, purified and reverse transcribed into cDNA that was
analyzed by quantitative real-time PCR. Sequences of primer
pairs are displayed in Table S1. The data were normalized using
two housekeeping genes (YWHAZ and CANX) as references, and
reported to the corresponding transcript level in uninfected control
mice. Assayed cytokines were TNF-a, IL-12p40, IL-10, IL-13, IL-
17, TGF-b and IFN-c. When gene expression was upregulated
during the course of infection, a peak value was obtained at day 8
post-infection without significant differences between wild-type
(WT) and ChemR23
2/2 mice, except for IL-12p40 (,3-fold
higher values at days 8 and 10 post-infection in ChemR23
2/2
mice; p,0.05). (B) IFN-c in serum and BAL fluids, as well as IL-
1b, IL-5 and IL-10 in lung homogenates were measured by ELISA
in ChemR23
2/2 and WT mice before and at various time points
after PVM infection. No significant difference was observed for
these cytokines. Data are the mean 6 SEM for groups of at least
five animals. *, p,0.05; **, p,0.01.
(TIF)
Figure S3 Higher myeloperoxydase activity in the lung
of infected ChemR23-deficient mice. Myeloperoxydase
(MPO) activity was assayed in lung homogenates from wild-type
(WT) and ChemR23
2/2 mice, 9 days after viral inoculation or
PBS instillation. Cell pellets from homogenized lungs were
resuspended in PBS containing 13.7 mM of hexadecyltrimethyl
ammonium bromide (HTAB) and 5 mM EDTA. Following
centrifugation, supernatants were harvested and diluted in Hanks’
balanced salt solution (HBSS) containing 1 mM HTAB, 0.4 mM
EDTA, 0.15 mM of o-dianisidine dihydrochloride solution and
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stopped with 25 ml of 1% NaN3. The MPO activity was
determined by measuring the absorbance at 460 nm against
medium. No difference was observed between uninfected WT and
ChemR23
2/2 mice, whereas infected ChemR23
2/2 mice
presented a significantly higher MPO activity than infected WT
mice. The data represent the mean 6 SEM for groups of seven
animals and are representative of three independent experiments.
**, p,0.01.
(TIF)
Figure S4 Assessment of the specificity of pDC deple-
tion by the 120G8 antibody. To investigate the role of pDCs in
the stronger inflammatory response observed in infected
ChemR23
2/2 mice, pDC depletion experiments were performed.
This was achieved by using a commercially available antibody
(120G8). To assess the specificity of this depletion procedure,
spleens from wild-type (WT) and ChemR23
2/2 (KO) mice treated
or not by the 120G8 antibody were obtained at day 8 post-
infection. Cells were isolated and stained for myeloid dendritic
cells (mDCs) (CD11c
+ CD11b
+ B220
2 mPDCA
2), macrophages
(F4-80
+ CD11b
+ CD11c
2), T (CD3
+ CD19
2 F4-80
2) and B
(CD19
+ CD3
2 F4-80
2) lymphocytes. There was a mild but
significant (p,0.05) decrease in the proportion of B cells in
depleted WT (but not ChemR23
2/2) mice, as compared to
control IgG-treated mice. No effect of the depleting antibody was
observed for mDCs, macrophages and T cells. Data are the mean
6 SEM for groups of five animals. *=p,0.05.
(TIF)
Figure S5 Production of IFN-a and IL-12p40 is not
impaired in ChemR23
2/2 pDCs. The capacity of pDCs
purified from wild-type (WT) and ChemR23
2/2 mice to
synthesize and secrete type I IFNs and IL-12p40 subunit was
studied following stimulation by CpG (a TLR9 agonist). pDCs
were prepared from spleen cells as described, resuspended at a
density of 10
5 cells/ml, stimulated in vitro by CpG (3 mg/ml), and
the production of IFN-a and IL-12p40 was assayed by ELISA on
the supernatant collected 24 hours later. Experiments were
performed in triplicates. No differences were observed for IFN-a
(91.163.6 versus 109.167.6 pg/ml for respectively WT and
ChemR23
2/2 pDCs; p.0.05), and IL-12 p40 (2256623 versus
2303627 pg/ml for respectively WT and ChemR23
2/2 pDCs;
p.0.05). Data represent the mean +/2 SEM (n=3).
(TIF)
Figure S6 Chemerin has no chemotactic activity for
pDCs purified from ChemR23-deficient mice. (A) PDCs
were purified from spleen cells as described. Over 90% of the
purified cells were identified as CD11b
2 CD11c
+ Gr-1
+ mPDCA
+
cells, which correspond to pDCs. (B) A chemotaxis assay was
performed with pDCs from wild-type (WT) (left panel) and
ChemR23
2/2 mice (right panel) using a 48-well microchemotaxis
Boyden chamber with polycarbonate membranes (5 mm pores).
The cell suspension (10
4 cells in 50 ml) was placed in the upper
chamber. The lower wells contained 30 ml of medium (RPMI)
with different concentrations of mouse recombinant chemerin or
CXCL12 (used as positive control), and the chamber was
incubated at 37uC for 90 min. The membrane was removed
and cells that migrated to the lower side of the membrane were
washed, fixed, stained with Hoechst, and counted with the ImageJ
software. All conditions were tested in triplicate. Controls were
performed in the absence of chemoattractant in the lower wells.
The results were expressed as migration ratio (mean cell number
per well with chemoattractant over mean cell number per well in
the absence of chemoattractant). As expected, only pDCs purified
from WT mice migrated with a classical bell-shaped curve in
response to increasing amounts of recombinant chemerin, with a
peak corresponding to 0.1 and 1 nM concentrations.
(TIF)
Figure S7 IL-6 and IFN-c levels in BAL fluid of
ChemR23
2/2 mice receiving pDCs from either wild-
type or ChemR23
2/2 mice. 10
6 pDCs from wild-type (WT) or
ChemR23
2/2 (KO) mice were transferred intravenously into
ChemR23
2/2 mice at the time of infection (n=7 per group).
Infected WT and KO mice receiving a saline solution were used as
controls (n=5 per group). Mice were sacrificed 14 days after
infection and cytokine levels were analyzed in BAL fluids using
ELISA. Histograms show the mean 6 SEM of IL-6 and IFN-c
levels expressed as pg/ml. *, p,0.05; **, p,0.01, ***, p,0.001.
(TIF)
Table S1 Sequence of primers used for quantitative RT-
PCR.
(DOC)
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